TA178: Renal cell carcinoma
This is a discussion on TA178: Renal cell carcinoma within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Renal cell carcinoma . It links to the published guidance and key documents. ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-01-2010, 12:51 PM
|
|||
|
|||
TA178: Renal cell carcinoma
The summary for the published technology appraisal on Renal cell carcinoma . It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA169: Renal cell carcinoma - sunitinib | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA178: Renal cell carcinoma | industry_news | Updates from the Technology Assessment Authorities | 0 | 08-26-2009 12:26 AM |
| Everolimus Potential Alternative for Metastatic Renal Cell Carcinoma | industry_news | Other Clinical Pharmacy News | 0 | 07-24-2008 11:51 AM |
| Reverse Transcriptase Inhibitors Promising Against Renal Clear-Cell Carcinoma | industry_news | Other Clinical Pharmacy News | 0 | 07-17-2008 12:42 PM |
| Vaccine Shows No Benefit in Renal Cell Carcinoma | industry_news | Other Clinical Pharmacy News | 0 | 07-07-2008 08:54 PM |
© 2008 DrugManagementForum™ powered by |
 |